FluxMPS™ MCDB 153 Medium: 1X Liquid
FluxMPS™ DCP-M153H1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) MCDB 153 + HEPES formulation engineered for serum-free or low-protein culture of Human Epidermal Keratinocytes and related primary cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. The 0.04 µm final filtration stage delivers the trace element matrix (zinc, copper, selenium, manganese) as fully dissolved ions rather than particulate aggregates, and every manufacturing batch is released to an endotoxin specification of < 0.05 EU/mL. Formulation: [+] 1.081 g/L Glucose, [+] L-Glutamine, [+] Sodium Pyruvate, [+] Sodium Bicarbonate, [+] 28 mM HEPES, [+] Trace Elements.
- Trace element formulation — zinc, copper, selenium and manganese for metalloenzyme support and antioxidant activity in serum-free culture
- Formulated for Human Epidermal Keratinocytes, CHO cells and Chicken Embryo Fibroblasts
- 28 mM HEPES (pKa 7.3 at 37°C) supplemented with 14 mM sodium bicarbonate — buffering suited to open-top chips and atmospheric platforms
- 0.04 µm final filtration stage — trace elements delivered as dissolved ions, not particulate aggregates that could foul microfluidic channels
- Quadruple-stage filtration train: 0.1 µm Prefiltration I → 0.04 µm Final filtration I → 0.1 µm Prefiltration II → 0.04 µm Final filtration II — Polish
- Endotoxin release specification < 0.05 EU/mL (LAL, USP <85>), tested per manufacturing batch
- Manufactured under an ISO 13485:2016 quality management system; Ultrapure Type 1 water (18.2 MΩ·cm) and ISO Class 5 (Class 100) aseptic fill
- Cell typesHuman Epidermal Keratinocytes
- Glucose1081 mg/L (1.081 g/L)
- HEPES28 mM (pKa 7.3 at 37°C)
- Sodium Bicarbonate14 mM (1176 mg/L)
- pH (USP <791>)7.4
- Osmolality (USP <785>)310–350 mOsm/kg H2O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2
- Storage2–8°C, away from light
- Shelf Life12 months from date of manufacture, unopened
Engineered where standard media fails
MCDB media formulated for primary cells contain trace element salts that can form subvisible particulate aggregates when filtered at 0.22 µm under typical manufacturing conditions. These aggregates clog microfluidic channels and disrupt trace metal bioavailability. FluxMPS™ addresses these failure modes with a four-stage, sub-0.04 µm filtration train and a batch-release endotoxin specification of < 0.05 EU/mL.
Particle-free trace element delivery
0.04 µm filtration keeps trace metal salts fully dissolved — reducing the risk of aggregate deposition in chip channels or culture vessels where trace metal precipitation could alter bioavailability.
Serum-free primary cell support
The trace element composition supports metalloenzyme activity (SOD, GPx, carbonic anhydrase) relevant to primary cell survival and function without serum supplementation.
Ultrapure-grade water
Ultrapure Type 1 water (18.2 MΩ·cm) limits ionic and organic-carbon contaminants that could compete with trace element uptake by low-serum primary cells.
Low-endotoxin release specification
Every manufacturing batch is released to an endotoxin specification of < 0.05 EU/mL (LAL, USP <85>), relevant for inflammation-sensitive primary cell models cultured without serum.
HEPES-stabilized pH
28 mM HEPES (pKa 7.3 at 37°C), supplemented with sodium bicarbonate, supports stable pH for primary cell culture across open and closed chip formats.
Customization on demand
pH, glucose, trace element concentrations, HEPES, and growth factor co-formulations available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages reaching a final 0.04 µm polish under ISO Class 5 aseptic conditions — delivering mycoplasma-retentive filtration and particle-free trace element delivery beyond what conventional 0.22 µm filtered MCDB media can achieve.
-
1
0.1 µm Prefiltration I
Removes large aggregates, including trace metal salt precipitates, protecting the first 0.04 µm cartridge from fouling.
-
2
0.04 µm Final filtration I
Mycoplasma-retentive final filter (mycoplasma range 0.2–0.3 µm); retains residual fine particulates not removed by standard 0.22 µm filtration.
-
3
0.1 µm Prefiltration II
A second, dedicated prefilter protecting the second 0.04 µm cartridge — redundancy, not polishing of the first pass.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter ahead of ISO Class 5 aseptic fill & finish.
Performance vs. conventional MCDB media
A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration.
© Diagnocine® — DCP-M153H1X
Specialized cell models & OoC applications
FluxMPS™ DCP-M153H1X was formulated for Human Epidermal Keratinocytes, CHO cells and Chicken Embryo Fibroblasts in low-protein or serum-free conditions. The 0.04 µm filtered trace element matrix supports use in microfluidic chip architectures where conventional MCDB media can cause trace metal particulate fouling.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra-filtered MPS Grade variant is available for automated bioreactor perfusion, where trace metal salt nanoparticulates in standard MCDB media can cause valve fouling.
- Trace Metal Nanoparticulate Removal: 10 nm filtration removes sub-0.04 µm metal salt colloids not detected by standard QC
- Valve & Sensor Protection: Reduces micro-fouling risk from trace element aggregates in automated systems
- Extended Perfusion Stability: Consistent trace element delivery over weeks-long primary cell culture
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Organ-on-a-Chip & MPS
0.04 µm filtration reduces microchannel clogging risk. Trace elements are delivered particle-free, limiting aggregate deposition in chip channels.
Skin-on-Chip
FluxMPS™ MCDB 153 + HEPES supports mycoplasma-retentive filtration and trace element fidelity for skin-on-chip models in serum-free or low-protein conditions.
Epidermal Barrier OoC
Supports epidermal barrier organ-on-a-chip models requiring particle-free trace element delivery and low-endotoxin culture conditions.
CHO Bioproduction
Trace element and HEPES-buffered formulation compatible with CHO cell culture workflows requiring particle-free, low-endotoxin media.
Wound Healing Assays
Serum-free MCDB 153 + HEPES formulation supports keratinocyte and fibroblast wound healing assay models.
Keratinocyte Differentiation
Trace element and vitamin profile supports keratinocyte differentiation studies in low-protein or serum-free conditions.
Analytical release specifications
Every lot released against the full specification matrix. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] 1.081 g/L Glucose, [+] L-Glutamine, [+] Sodium Pyruvate, [+] Sodium Bicarbonate, [+] 28 mM HEPES, [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] Trace Elements |
| Appearance | Red-colored, clear solution |
| Glucose | 1081 mg/L (1.081 g/L) |
| HEPES | 28 mM (6600 mg/L; pKa 7.3 at 37°C) |
| Sodium Pyruvate | 55 mg/L |
| Trace Elements | Present (zinc, copper, selenium, manganese, vanadium, molybdenum, nickel, tin, silicon) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 310–350 mOsm/kg H2O |
| Total ingredients | 55 components across 4 categories |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (batch release specification) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> | NMT 25/mL |
| Particulate ≥25 µm USP <788> | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, away from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | HEPES-buffered (28 mM) with supplemental sodium bicarbonate (14 mM); reduced CO2 dependence for open-top/atmospheric platforms. If a controlled atmosphere is used, approximately 3% CO2 is consistent with the bicarbonate component at pH 7.4 |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
MCDB 153 + HEPES: 55 ingredients verified per lot with CAS numbers for raw-material traceability. Contains trace elements for metalloenzyme support and antioxidant activity. HEPES (28 mM ≈ 6600 mg/L) is listed under OTHERS.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Ammonium metavanadate | 7803-55-6 | 0.000585 |
| Calcium chloride dihydrate | 10035-04-8 | 4.411 |
| Cupric sulfate pentahydrate | 7758-99-8 | 0.00275 |
| Disodium hydrogen phosphate anhydrous | 7558-79-4 | 284.088 |
| Ferrous sulfate heptahydrate | 7782-63-0 | 1.390 |
| Magnesium chloride hexahydrate | 7791-18-6 | 122.000 |
| Manganese sulfate | 7785-87-7 | 0.000151 |
| Molybdic acid ammonium tetrahydrate | 12054-85-2 | 0.00124 |
| Nickel chloride | 7718-54-9 | 0.00012 |
| Potassium chloride | 7447-40-7 | 111.830 |
| Sodium acetate anhydrous | 127-09-3 | 301.530 |
| Sodium bicarbonate | 144-55-8 | 1176.00 |
| Sodium chloride | 7647-14-5 | 7599.000 |
| Stannous chloride monohydrate | 10025-69-1 | 0.000113 |
| Sodium metasilicate nonahydrate | 13517-24-3 | 0.1421 |
| Sodium selenite | 10102-18-8 | 0.0038 |
| Zinc sulfate heptahydrate | 7446-20-0 | 0.144 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 7.510 |
| L-Alanine | 56-41-7 | 8.910 |
| L-Arginine hydrochloride | 1119-34-2 | 210.700 |
| L-Asparagine monohydrate | 5794-13-8 | 15.000 |
| L-Aspartic acid | 56-84-8 | 3.990 |
| L-Cysteine hydrochloride monohydrate | 7048-04-6 | 42.040 |
| L-Glutamic acid | 56-86-0 | 14.710 |
| L-Glutamine | 56-85-9 | 877.200 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 16.770 |
| L-Isoleucine | 73-32-5 | 1.968 |
| L-Leucine | 61-90-5 | 65.600 |
| L-Lysine hydrochloride | 657-27-2 | 18.270 |
| L-Methionine | 63-68-3 | 4.480 |
| L-Phenylalanine | 63-91-2 | 4.960 |
| L-Proline | 147-85-3 | 34.530 |
| L-Serine | 56-45-1 | 63.060 |
| L-Threonine | 72-19-5 | 11.910 |
| L-Tryptophan | 73-22-3 | 3.060 |
| L-Tyrosine disodium salt dihydrate | 69847-15-0 | 3.410 |
| L-Valine | 72-18-4 | 35.130 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 13.960 |
| D-Biotin | 58-85-5 | 0.0146 |
| D-Pantothenic acid (hemicalcium) | 137-08-6 | 0.238 |
| Folic acid | 59-30-3 | 0.790 |
| Niacinamide | 98-92-0 | 0.03663 |
| Pyridoxine hydrochloride | 58-56-0 | 0.06171 |
| Riboflavin | 83-88-5 | 0.0376 |
| Thiamine hydrochloride | 67-03-8 | 0.337 |
| Vitamin B12 | 68-19-9 | 0.407 |
| myo-Inositol | 87-89-8 | 18.020 |
| OTHERS | ||
| Adenine hydrochloride | 2922-28-3 | 30.880 |
| D-Glucose | 50-99-7 | 1081.000 |
| HEPES | 7365-45-9 | 6600.000 |
| Phenol red sodium salt | 34487-61-1 | 1.242 |
| Putrescine dihydrochloride | 333-93-7 | 0.161 |
| Sodium pyruvate | 113-24-6 | 55.00 |
| Thioctic acid | 1077-28-7 | 0.206 |
| Thymidine | 50-89-5 | 0.727 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system, with particular attention to trace element dissolution and particulate removal during MCDB formulation.
ISO 13485:2016 Quality Management
Manufactured under ISO 13485:2016-certified facilities. Final QA at the DiagnoCine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm — relevant for trace element MCDB formulations where ionic contaminants could compete with zinc, copper, and selenium uptake.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch production, per-lot traceability, and a Certificate of Analysis for every batch — trace element concentrations verified against specification.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
Endotoxin — USP <85> BET
LAL assay; batch release specification < 0.05 EU/mL.
Particulate — USP <788> Method 1
Light obscuration: NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Target: 310–350 mOsm/kg H2O.
Documentation & CoA
Full CoA with raw-material traceability available for every lot on request.
How DCP-M153H1X compares
FluxMPS™ DCP-M153H1X vs. conventional 0.22 µm-filtered MCDB 153 + HEPES formulations.
| Parameter | DCP-M153H1X (FluxMPS™) | Conventional MCDB 153 + HEPES (0.22 µm filtered) |
Standard Alt. MCDB (0.22 µm filtered) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Not specified | Not specified |
| MCDB 153 (Ham's F-12 modification) with 28 mM HEPES and Trace Elements — for keratinocyte, CHO, and fibroblast OoC | check_circle Yes | cancel No | cancel No |
| Trace element delivery | Particle-free (0.04 µm) | May contain aggregates | May contain aggregates |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple) | 1 | 1 |
| Mycoplasma barrier filtration | check_circle Yes (0.1 µm mycoplasma-retentive) | cancel No | cancel No |
| Endotoxin (release specification) | FluxMPS™ — < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate tested | check_circle Yes | cancel No | cancel No |
| Water quality | Type 1, 18.2 MΩ·cm | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatible | check_circle Yes (0.04 µm filtered) | cancel Higher clogging risk | cancel Higher clogging risk |
| Custom formulation | check_circle Available | cancel Fixed | cancel Fixed |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-M153H1X MCDB 153 + HEPES.
Supporting literature
Key publications supporting MCDB 153 + HEPES for Human Epidermal Keratinocyte culture and organ-on-a-chip applications.
- Ham RG, McKeehan WL. Media and growth requirements. Methods Enzymol. 1979;58:44–93. doi:10.1016/S0076-6879(79)58127-6
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Campisi M, et al. 3D self-organized microvascular model of the human blood-brain barrier. Biomaterials. 2018;180:117–129. doi:10.1016/j.biomaterials.2018.07.014
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j

